Stuttgart, 02 November 2021 – Group (“Exyte”) has completed the all-share acquisition of US-based Critical Process Systems Group (“CPS”) from Wynnchurch Capital. The transaction enhances Exyte’s global offering for customers in the semiconductor and biopharma and life sciences businesses.
“Adding CPS to the Exyte Group strengthens our services and process equipment portfolio, providing innovative product solutions and adding more value for our customers by providing immediate support for capital expansion efforts,” said Dr. Büchele, CEO of Exyte. “We look forward to welcoming more than 400 employees with expert knowledge and technical competencies to Exyte.”
Brian Crumbaugh, Partner at Wynnchurch, stated, “CPS represented an opportunity to invest in a company with a market leading product and service offering. We are very proud and appreciative of the management team’s leadership and accomplishments during our ownership period. Exyte is an ideal partner for CPS as it looks to execute on its growth plan in the upcoming years.” “The closing of this acquisition opens a whole new chapter for the CPS Group companies,” said Dmitry Shashkov, CEO of CPS Group. “For our customers, it means better service and more resources to support their growth. For our people, this will be an exciting time as we are joining a larger, well established company with great resources and worldwide name recognition.”
CPS will become part of the Business Area Technology and Services (T&S), led by Michael Löffelmann, SVP of T&S, with the existing management team of CPS remaining in place. “We expect the combination of the two businesses to prove highly successful, thanks to a complementary regional footprint and portfolio synergies. The joint project opportunities we have identified and our shared values will lead to a further acceleration of business growth,” said Michael Löffelmann.